
Tempest Therapeutics: European Medicines Agency Grants Orphan Drug Designation To Amezalpat
(RTTNews) - Tempest Therapeutics (TPST) announced that the European Medicines Agency has granted Orphan Drug Designation to amezalpat, an oral, small molecule, selective PPAR antagonist for the treatm...
- June 05, 2025 05:46 AM PDT
- EODHD

Saia reports decrease in quarter-to-date less-than-truckload shipments
Transportation services provider Saia (NASDAQ:SAIA [https://seekingalpha.com/symbol/SAIA]) said [https://seekingalpha.com/pr/20127463-saia-provides-second-quarter-ltl-operating-data] its less-than-tru...
- June 05, 2025 05:46 AM PDT
- EODHD

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
Follow-on study (“PoC 2”) builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology E...
- June 05, 2025 05:45 AM PDT
- EODHD

The Scotts Miracle-Gro To Present At William Blair Growth Stock Conference; Webcast At 9:40 AM ET
(RTTNews) - The Scotts Miracle-Gro Co. (SMG) will present at the William Blair 45th Annual Growth Stock Conference, Chicago. The event is scheduled to begin at 9:40 AM ET on June 5, 2025. To access th...
- June 05, 2025 05:40 AM PDT
- EODHD

Bold Ventures increases private placement to $1.07M with additional flow-through units
* Bold Ventures (TSXV:BOL:CA [https://seekingalpha.com/symbol/BOL:CA]) has increased its non-brokered private placement by an additional $19,000 in flow-through (FT [https://seekingalpha.com/symbol/FT...
- June 05, 2025 05:32 AM PDT
- EODHD

Veolia Earns Intel’s 2025 EPIC Supplier Award
Veolia is one of only 37 Intel EPIC Supplier Award recipients in all of Intel’s global supply chain. BOSTON, June 05, 2025--(BUSINESS WIRE)--Veolia is proud to announce that it has earned the exclusiv...
- June 05, 2025 05:30 AM PDT
- EODHD

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AIT...
- June 05, 2025 05:28 AM PDT
- EODHD

Inspire Veterinary Partners acquires central Florida animal hospital
* Inspire Veterinary Partners (NASDAQ:IVP [https://seekingalpha.com/symbol/IVP]) has acquired 100% ownership interest in DeBary Animal Clinic in DeBary Florida, north of Orlando. * The acquisition mar...
- June 05, 2025 05:26 AM PDT
- EODHD

Tesla stock falls again as Musk's 'KILL the BILL' screed hits Trump tax bill's progress
Tesla (TSLA) stock slumped again on Thursday as the fallout continued to emerge from the very public policy blowout between President Trump and Tesla CEO Elon Musk. "Call your Senator, Call your Congr...
- June 05, 2025 05:14 AM PDT
- EODHD

Walmart's Sam's Club to remove synthetic dyes from private brand by year end
(Reuters) -Walmart-owned Sam's Club said on Thursday it would eliminate over 40 ingredients, including artificial colors and aspartame, from private label brand Member's Mark by the end of this year....
- June 05, 2025 05:13 AM PDT
- EODHD